Double maintains 1 strategies that include ANIK - Anika Therapeutics, Inc.
Current Value
$12.241 Year Return
Current Value
$12.241 Year Return
Name | Correlation | Market Cap | Return % (1 Year) | Div Yield % |
---|---|---|---|---|
NVRI | 51.61% | $619.83M | -7.34% | 0.00% |
NSIT | 48.80% | $4.30B | -35.63% | 0.00% |
HII | 47.01% | $8.95B | -10.93% | 2.33% |
GMED | 46.78% | $7.83B | -9.59% | 0.00% |
SRI | 45.71% | $139.23M | -69.38% | 0.00% |
IRMD | 45.21% | $684.84M | +26.28% | 1.15% |
IOVA | 43.98% | $587.72M | -83.13% | 0.00% |
WSC | 43.75% | $5.39B | -25.37% | 0.24% |
OTEX | 43.67% | $7.25B | -8.83% | 3.71% |
MG | 43.22% | $252.83M | -3.24% | 0.00% |
ARW | 41.75% | $6.26B | -7.07% | 0.00% |
APTV | 41.06% | $14.83B | -17.24% | 0.00% |
SNN | 40.86% | $12.58B | +11.22% | 2.63% |
MET | 39.87% | $54.01B | +9.51% | 2.74% |
REGN | 39.84% | $63.16B | -39.57% | 0.00% |
PATK | 39.53% | $2.91B | +15.98% | 2.41% |
VREX | 39.50% | $327.44M | -48.23% | 0.00% |
ICE | 39.32% | $100.30B | +27.53% | 1.04% |
NNBR | 39.22% | $112.50M | -37.01% | 0.00% |
XYL | 39.12% | $30.81B | -11.26% | 1.17% |
Name | Correlation | Market Cap | Return % (1 Year) | Div Yield % |
---|---|---|---|---|
K | 0.06% | $28.49B | +32.17% | 2.77% |
LAUR | 0.06% | $3.37B | +39.93% | 0.00% |
BMY | 0.06% | $93.23B | +3.85% | 5.32% |
MUSA | -0.09% | $8.91B | +2.63% | 0.53% |
TTMI | 0.12% | $2.96B | +57.04% | 0.00% |
CHT | -0.15% | $33.79B | +11.52% | 3.35% |
OCFT | 0.20% | $265.28M | +232.26% | 0.00% |
ALHC | 0.23% | $2.95B | +113.16% | 0.00% |
EDU | -0.28% | $7.99B | -41.11% | 0.00% |
EXEL | 0.29% | $12.62B | +117.90% | 0.00% |
PRPO | -0.37% | $10.84M | +15.14% | 0.00% |
BLDP | -0.38% | $410.77M | -56.37% | 0.00% |
CLLS | 0.42% | $105.26M | -51.97% | 0.00% |
LYFT | 0.46% | $6.83B | -4.25% | 0.00% |
TXMD | 0.48% | $16.90M | -31.13% | 0.00% |
CANG | 0.48% | $275.23M | +149.39% | 0.00% |
GO | 0.48% | $1.37B | -35.98% | 0.00% |
MKTX | -0.52% | $8.01B | -1.42% | 1.39% |
VSA | -0.54% | $7.04M | -49.24% | 0.00% |
CODI | 0.56% | $580.07M | -65.16% | 12.97% |
Name | Correlation | AUM | Expense Ratio |
---|---|---|---|
IBTH | 0.16% | $1.53B | 0.07% |
BNO | 0.30% | $86.13M | 1% |
DFNM | 0.33% | $1.53B | 0.17% |
IBMN | 0.39% | $446.12M | 0.18% |
UGA | 0.43% | $73.47M | 0.97% |
FXE | -0.44% | $525.40M | 0.4% |
STPZ | -0.48% | $446.46M | 0.2% |
FTSD | 0.54% | $212.46M | 0.25% |
USO | 0.57% | $956.18M | 0.6% |
BWX | -0.67% | $1.41B | 0.35% |
BSMW | -0.68% | $102.62M | 0.18% |
IBTG | -0.73% | $1.88B | 0.07% |
UUP | -0.76% | $292.27M | 0.77% |
SPTS | -0.88% | $5.76B | 0.03% |
ICSH | -0.97% | $6.10B | 0.08% |
IBTI | 1.09% | $995.39M | 0.07% |
FTSM | -1.24% | $6.54B | 0.45% |
DBE | 1.31% | $48.48M | 0.77% |
LDUR | 1.38% | $849.09M | 0.5% |
CORN | 1.43% | $49.57M | 0.2% |
Name | Correlation | AUM | Expense Ratio |
---|---|---|---|
VIXY | -28.76% | $109.64M | 0.85% |
TAIL | -25.77% | $140.49M | 0.59% |
BTAL | -20.35% | $361.41M | 1.43% |
XHLF | -13.12% | $1.46B | 0.03% |
BIL | -12.54% | $45.95B | 0.1356% |
FXY | -12.44% | $838.61M | 0.4% |
BILS | -11.86% | $3.96B | 0.1356% |
SGOV | -11.08% | $45.91B | 0.09% |
ULST | -9.56% | $637.77M | 0.2% |
KCCA | -9.43% | $97.18M | 0.87% |
XBIL | -9.02% | $782.40M | 0.15% |
IBTF | -8.74% | $2.12B | 0.07% |
GBIL | -8.37% | $6.17B | 0.12% |
XONE | -8.29% | $603.24M | 0.03% |
BILZ | -7.79% | $876.85M | 0.14% |
IVOL | -7.10% | $353.94M | 1.02% |
TFLO | -6.37% | $7.06B | 0.15% |
SHV | -6.12% | $20.94B | 0.15% |
TBIL | -5.75% | $5.76B | 0.15% |
SCHO | -5.23% | $10.87B | 0.03% |
Name | Correlation | AUM | Expense Ratio |
---|---|---|---|
XSLV | 38.66% | $290.69M | 0.25% |
XSVM | 38.06% | $603.10M | 0.37% |
KJAN | 38.04% | $305.13M | 0.79% |
VTWO | 37.99% | $12.07B | 0.07% |
DES | 37.96% | $1.86B | 0.38% |
GSSC | 37.88% | $538.65M | 0.2% |
EES | 37.85% | $588.44M | 0.38% |
IWM | 37.76% | $63.95B | 0.19% |
VIOO | 37.73% | $2.88B | 0.1% |
SMDV | 37.72% | $663.17M | 0.4% |
IJS | 37.72% | $6.27B | 0.18% |
IWN | 37.71% | $11.10B | 0.24% |
IJR | 37.70% | $79.01B | 0.06% |
SLYV | 37.64% | $3.75B | 0.15% |
SPSM | 37.63% | $11.14B | 0.03% |
CPRJ | 37.57% | $48.43M | 0.69% |
VIOV | 37.55% | $1.27B | 0.1% |
FNDA | 37.47% | $8.30B | 0.25% |
IWC | 37.41% | $766.88M | 0.6% |
PRFZ | 37.37% | $2.33B | 0.34% |
Name | Correlation | Market Cap | Return % (1 Year) | Div Yield % |
---|---|---|---|---|
UUU | -37.18% | $4.93M | +40.20% | 0.00% |
ROOT | -27.85% | $2.18B | +119.56% | 0.00% |
ETR | -21.48% | $35.25B | +44.34% | 4.30% |
PAYC | -16.51% | $14.83B | +41.64% | 0.59% |
NXT | -16.19% | $8.85B | +40.58% | 0.00% |
ATEC | -15.91% | $1.86B | +11.46% | 0.00% |
MO | -15.83% | $97.80B | +26.35% | 6.94% |
CSV | -15.57% | $681.07M | +62.61% | 1.04% |
GOGO | -13.96% | $1.61B | +13.70% | 0.00% |
MDGL | -13.29% | $6.48B | +34.37% | 0.00% |
RBLX | -13.12% | $54.79B | +146.55% | 0.00% |
CPSH | -12.44% | $27.45M | +8.62% | 0.00% |
TK | -12.19% | $684.19M | +2.84% | 0.00% |
CBOE | -11.93% | $22.95B | +20.67% | 1.12% |
NGVC | -11.76% | $1.19B | +145.18% | 0.85% |
AVDL | -11.21% | $860.01M | -44.23% | 0.00% |
SXC | -10.88% | $748.32M | -16.29% | 4.13% |
PODD | -10.32% | $22.66B | +73.71% | 0.00% |
FMTO | -10.26% | $45.74M | -99.96% | 0.00% |
IP | -9.47% | $26.17B | +22.33% | 3.74% |
Yahoo
BEDFORD, Mass., May 12, 2025 (GLOBE NEWSWIRE) -- Anika Therapeutics, Inc. (NASDAQ: ANIK), a global leader in the osteoarthritis (“OA”) pain management and regenerative solutions spaces focused on early intervention orthopedics, today announced that on May 1, 2025, Anika granted non-statutory stock options (“Options”) covering an aggregate of 5,000 shares of common stock at a per share exercise price of $14.46, which equaled the closing price of common stock on the Nasdaq Global Select Market (“C
Yahoo
Companies in The News Are: ENB,PAA,ANIK,GOGO
Finnhub
BEDFORD - Anika Therapeutics, Inc. , a global leader in the osteoarthritis pain management and regenerative solutions spaces focused on early intervention orthopedics, announced financial results for...
Yahoo
Anika Therapeutics ( NASDAQ:ANIK ) First Quarter 2025 Results Key Financial Results Revenue: US$26.2m (down 35% from 1Q...
Yahoo
Anika Therapeutics Inc (ANIK) showcases strong commercial growth and strategic advancements despite facing pricing pressures and manufacturing hurdles.
Yahoo
Anika (ANIK) delivered earnings and revenue surprises of -166.67% and 8.50%, respectively, for the quarter ended March 2025. Do the numbers hold clues to what lies ahead for the stock?